Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: Eur J Nucl Med Mol Imaging. 2011 Mar 4;38(7):1335–1343. doi: 10.1007/s00259-011-1765-5

Fig. 3.

Fig. 3

Biodistribution studies after non-invasive PET scans. a Biodistribution of 64Cu-DOTA-TRC105 in 4T1 tumour-bearing mice at 24 and 48 h post-injection (n = 3). b Biodistribution of 64Cu-DOTA-TRC105 and 64Cu-DOTA-cetuximab at 48 h post-injection (n = 3). *: P < 0.05.